Element Biosciences Aviti¿ 24 Sequencing And Spati
Sector: Residential • Location: United States of America
Source: SAM.gov
The purpose of this acquisition is to enhance the shared research capabilities of the National Cancer Institute (NCI), Center for Cancer Research (CCR), by acquiring an Element Biosciences AVITI24 Sequencing System for joint operation by the CCR Genomics Core and the CCR High-Throughput Imaging Facility (HiTIF).
- Status
- Prospective
- Sector
- Residential, Manufacturing (Industrial), Commercial
- Location
- United States of America
- Updated
- 3 Nov 2026
- Source
- SAM.gov
ConstructChat
Ask ConstructChat about Element Biosciences Aviti¿ 24 Sequencing And Spati
Pick a question to edit it, or write your own.
First answer free · no account
Tender Information FAQ
Tender Information
Participants
| Not available for this record. |
Status
Original status | solicitation |
Taiyo status | Prospective |
Taiyo last update | 2026-11-03 |
Contact
| Not available for this record. |
Description
Description | The purpose of this acquisition is to enhance the shared research capabilities of the National Cancer Institute (NCI), Center for Cancer Research (CCR), by acquiring an Element Biosciences AVITI24 Sequencing System for joint operation by the CCR Genomics Core and the CCR High-Throughput Imaging Facility (HiTIF). |
Original sector | Not Identified |
Location
Country | United States of America (USA) |
Source
Source | SAM.gov |
URL |
More Details
Record type | Tender |
Sector | Residential, Manufacturing (Industrial), Commercial |
Article published date | 2026-08-12 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this tender
- News and media coverage
- Technical research
Free account · no card · lands you back on this tender